Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Long-Term Deferred Tax: 2010-2025

Historic Long-Term Deferred Tax for BIO-TECHNE (TECH) over the last 2 years, with Jun 2025 value amounting to $10.3 million.

  • BIO-TECHNE's Long-Term Deferred Tax was N/A to $10.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.3 million, marking a year-over-year change of. This contributed to the annual value of $10.3 million for FY2025, which is N/A change from last year.
  • As of FY2025, BIO-TECHNE's Long-Term Deferred Tax stood at $10.3 million, which was up 919.49% from $1.0 million recorded in FY2010.
  • In the past 5 years, BIO-TECHNE's Long-Term Deferred Tax ranged from a high of $10.3 million in FY2025 and a low of $10.3 million during FY2025.
  • Moreover, its 1-year median value for Long-Term Deferred Tax was $10.3 million (2025), whereas its average is $10.3 million.